Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 3 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 4 analysts offering 12 month price targets for Corvus Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 21.00 and a low estimate of 8.00. The median estimate represents a 15.07% increase from the last price of 8.69.
High | 141.7% | 21.00 |
Med | 15.1% | 10.00 |
Low | -7.9% | 8.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 12, 2024.
Average growth rate | -179.46% |
Average growth rate | -69.23% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼